Donald Kalkofen

Mr. Kalkofen has more than 20 years of experience as a chief financial officer and senior finance executive in the biotechnology, financial services and technology sectors, with experience in capital markets transactions, SEC reporting, U.S. GAAP compliance, internal controls and investor relations. Since May 2026, Mr. Kalkofen has served as Chief Financial Officer of Genvor Incorporated (OTCQB: GNVR), a biotechnology company, and since October 2024, he has served as principal and sole owner of Wave Financial Consulting LLC, a financial consulting practice. Mr. Kalkofen served as Chief Financial Officer of Alpha Cognition Inc. (Nasdaq: ACOG), a CNS-focused biotechnology company developing therapies for neurodegenerative disease, where he oversaw preparations for the company’s initial public offering and helped establish its banking, audit committee and investor relations functions.. Earlier in his career, Mr. Kalkofen held chief financial officer and senior finance positions at West Coast Bancorp and worked as an auditor at PricewaterhouseCoopers. Mr. Kalkofen holds a Bachelor of Arts in accounting from Washington State University and is a Certified Public Accountant (inactive).